Intrinsic Value of S&P & Nasdaq Contact Us

Biomea Fusion, Inc. BMEA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$20.20
+935.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Biomea Fusion, Inc. (BMEA) has a negative trailing P/E of -2.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -48.56%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+935.9%).
  • Trailing Earnings Yield -48.56% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $20.20 (+935.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 53/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
55/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — BMEA

Valuation Multiples
P/E (TTM)-2.1
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio4.31
P/S Ratio0.00
EV/EBITDA-0.7
Per Share Data
EPS (TTM)$-0.85
Book Value / Share$0.41
Revenue / Share$0.00
FCF / Share$-0.97
Yields & Fair Value
Earnings Yield-48.56%
Dividend Yield0.00%
Analyst Target$20.20 (+935.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -152.0 0.00 -8,668.42 0.00 -
2020 -34.2 -0.10 35.22 0.00 -
2021 -4.3 -0.02 0.99 0.00 -
2022 -3.0 -0.05 2.27 0.00 -
2023 -4.2 -0.18 2.93 0.00 -
2024 -1.0 -0.09 2.72 0.00 -
2025 -1.0 0.02 2.19 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.11 $0.00 $-1.2M -
2020 $-0.50 $0.00 $-5.32M -
2021 $-1.73 $0.00 $-41.22M -
2022 $-2.73 $0.00 $-80.02M -
2023 $-3.44 $0.00 $-117.26M -
2024 $-3.83 $0.00 $-138.43M -
2025 $-1.18 $0.00 $-61.8M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.95 $-1.41 – $-0.61 $3M $3M – $3M 5
2027 $-1.26 $-2.64 – $-0.64 $1.12M $1.12M – $1.12M 5
2028 $-0.95 $-1.26 – $-0.79 $6.19M $6.19M – $6.19M 4
2029 $-1.02 $-1.02 – $-1.02 $616M $616M – $616M 2
2030 $-0.08 $-0.08 – $-0.08 $107.05M $107.05M – $107.05M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message